A Versatile Orthotopic Nude Mouse Model for Study of Esophageal Squamous Cell Carcinoma

NFkB disrupts tissue polarity in 3D by preventing integration of microenvironmental signals

(2015) Sabine Becker-Weimann et al.   Oncotarget

The prognostic effect of perineural invasion in esophageal squamous cell carcinoma

(2014) Jie-Wei Chen et al.   BMC CANCER

Identification of genomic alterations in oesophageal squamous cell cancer

(2014) Yongmei Song et al.   NATURE

Genetic landscape of esophageal squamous cell carcinoma

(2014) Yi-Bo Gao et al.   NATURE GENETICS

Esophageal Adenocarcinoma and Its Rare Association with Barrett’s Esophagus in Henan, China

(2014) Shuzheng Liu et al.   PLoS One

Cancer statistics, 2013

(2013) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Diverse Mechanisms of AKT Pathway Activation in Human Malignancy

(2013) Mitchell Cheung et al.   CURRENT CANCER DRUG TARGETS

Oesophageal carcinoma

(2013) Arjun Pennathur et al.   LANCET

Polo-like Kinase Inhibitor Ro5203280 Has Potent Antitumor Activity in Nasopharyngeal Carcinoma

(2013) A. K. L. Cheung et al.   MOLECULAR CANCER THERAPEUTICS

Orthotopic mouse models for the preclinical and translational study of targeted therapies against metastatic human thyroid carcinoma with BRAFV600E or wild-type BRAF

(2013) Z A Antonello et al.   ONCOGENE

The incidence of esophageal adenocarcinoma continues to rise: analysis of period and birth cohort effects on recent trends

(2012) A. P. Thrift et al.   ANNALS OF ONCOLOGY

Bile Acid and Inflammation Activate Gastric Cardia Stem Cells in a Mouse Model of Barrett-Like Metaplasia

(2012) Michael Quante et al.   CANCER CELL

Hallmarks of Cancer: The Next Generation

(2011) Douglas Hanahan et al.   CELL

Caveolin-1 overexpression is associated with hepatocellular carcinoma tumourigenesis and metastasis

(2011) Edith Yuk Ting Tse et al.   JOURNAL OF PATHOLOGY

Tumor suppressor Alpha B-crystallin (CRYAB) associates with the cadherin/catenin adherens junction and impairs NPC progression-associated properties

(2011) Z Huang et al.   ONCOGENE

Cysteine-rich intestinal protein 2 (CRIP2) acts as a repressor of NF- B-mediated proangiogenic cytokine transcription to suppress tumorigenesis and angiogenesis

(2011) A. K. L. Cheung et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

PI3K/AKT/mTOR Pathway in Angiogenesis

(2011) Jayashree Karar et al.   Frontiers in Molecular Neuroscience

P70S6K 1 regulation of angiogenesis through VEGF and HIF-1α expression

(2010) Chuan-Xiu Bian et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

The establishment of a new mouse model with orthotopic esophageal cancer showing the esophageal stricture

(2010) Toshiaki Ohara et al.   CANCER LETTERS

The ECM protein LTBP-2 is a suppressor of esophageal squamous cell carcinoma tumor formation but higher tumor expression associates with poor patient outcome

(2010) Stephen Ho Kin Chan et al.   INTERNATIONAL JOURNAL OF CANCER

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

(2010) Jacques Ferlay et al.   INTERNATIONAL JOURNAL OF CANCER

Genetic Heterogeneity of Oesophageal Cancer in High-Incidence Areas of Southern and Northern China

(2010) Zhang Guohong et al.   PLoS One

Id-1 promotes tumorigenicity and metastasis of human esophageal cancer cells through activation of PI3K/AKT signaling pathway

(2009) Bin Li et al.   INTERNATIONAL JOURNAL OF CANCER

Continuing Rapid Increase in Esophageal Adenocarcinoma in England and Wales

(2008) Côme Lepage et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Mouse xenograft models vs GEM models for human cancer therapeutics

(2008) A. Richmond et al.   Disease Models & Mechanisms